MetLife Investment Advisors »

Ultragenyx Pharmaceutical shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $228k 4.8k 47.82
2023-09-30 $148k 4.2k 35.65
2023-06-30 $192k 4.2k 46.13
2023-03-31 $139k 3.5k 40.10
2022-12-31 $160k 3.4k 46.33
2022-09-30 $146k 3.5k 41.36
2022-06-30 $211k 3.5k 59.66
2022-03-31 $252k 3.5k 72.62
2021-09-30 $30k 328 90.19
2021-03-31 $2.7M 24k 113.86
2020-12-31 $3.4M 25k 138.43
2020-09-30 $2.0M 24k 82.19
2020-06-30 $2.0M 25k 78.21
2020-03-31 $1.0M 23k 44.43
2019-12-31 $1.0M 25k 42.71
2019-09-30 $1.0M 25k 42.76
2019-06-30 $1.4M 22k 63.51
2019-03-31 $1.5M 22k 69.36
2018-12-31 $879k 20k 43.46
2018-09-30 $2.4M 32k 76.35
2018-06-30 $1.7M 22k 76.87
2018-03-31 $1.0M 20k 50.99
2017-12-31 $849k 18k 46.36